Cortisol and cardiometabolic disease: a target for advancing health equity

Trends Endocrinol Metab. 2022 Nov;33(11):786-797. doi: 10.1016/j.tem.2022.08.002. Epub 2022 Oct 18.

Abstract

Stress, in both intrinsic psychosocial and extrinsic physical environmental forms, can impact the development of, and outcomes in, cardiovascular disease (CVD) through allostatic load. Cortisol is a core hormonal mediator of allostatic load produced in response to various stresses. Alterations in morning serum cortisol and daily diurnal cortisol have been associated with adiposity, dyslipidemia, incident diabetes, and CVDs such as hypertension. The review examines the role of cortisol as a key mechanistic link between stress physiology and cardiometabolic disease. Importantly, we discuss the role of targeting cortisol through pharmacological, behavioral, and environmental interventions to advance health equity in cardiometabolic disease.

Keywords: adiposity; adrenal; cardiometabolic disease; cortisol; diabetes; health equity; stress.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases*
  • Health Equity*
  • Humans
  • Hydrocortisone
  • Hypertension*
  • Stress, Psychological

Substances

  • Hydrocortisone